← FDA Drug Approvals (Drugs@FDA)

RISEDRONATE SODIUM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: IMPAX LABS INC · Approved 2018-06-29

Drug application

FDA Application #

ANDA205066

Application type

Abbreviated New Drug Application (Generic)

Brand name

RISEDRONATE SODIUM

Generic name

Risedronate Sodium

Active ingredients

RISEDRONATE SODIUM

Dosage form

TABLET, DELAYED RELEASE

Route

ORAL

Marketing status

Discontinued

Sponsor

IMPAX LABS INC

First approval

2018-06-29

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown